Race Oncology Limited
ASX:RAC.AX
1.585 (AUD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 0 | 4.003 | 1.812 | 1.322 | 0 | 0.708 | 0 | 0.387 | 0 | 0.159 | 0 | 0.229 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 0.769 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.141 | 0.373 | 0.048 | 0.545 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -0.769 | 3.863 | 1.672 | 1.181 | -0.141 | 0.567 | -0.141 | 0.247 | -0.141 | 0.019 | -0.141 | -0.144 | -0.048 | -0.375 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0 | 0.965 | 0.922 | 0.894 | 0 | 0.801 | 0 | 0.637 | 0 | 0.118 | 0 | -0.631 | 0 | -2.202 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 4.872 | 6.105 | 4.428 | 3.167 | 3.546 | 2.286 | 1.664 | 0.536 | 0.736 | 0.541 | 0.509 | 0.656 | 0.627 | 0.657 | 0.714 | 0.497 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0.461 | 0.453 | 0.949 | 0.576 | 0.302 | 0.313 | 0.343 | 0.327 | 0.275 | 0.212 | 0.201 | 0.217 | 0.256 | 0.262 | 0.261 | 0.193 | 0.238 | 0.13 | 0.074 | 0 | 0.005 | 0.002 |
Selling & Marketing Expenses
| 0.126 | 0.306 | 0.211 | 0.112 | 0.089 | 0.087 | 0.101 | 0.073 | 0.067 | 0.037 | 0.062 | 0.182 | 0.714 | 0.497 | 0.247 | 0.304 | 0.054 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 2.322 | 3.368 | 2.849 | 2.262 | 2.525 | 2.848 | 2.302 | 1.694 | 1.5 | 0.902 | 0.933 | 1.007 | 1.98 | 2.215 | 1.119 | 1.461 | 0.293 | 0.13 | 0.074 | 0 | 0.005 | 0.002 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 7.195 | 9.473 | 7.277 | 5.429 | 6.07 | 5.134 | 3.966 | 2.229 | 2.236 | 1.443 | 1.443 | 1.894 | 2.782 | 3.123 | 2.1 | 2.097 | 0.128 | 0.206 | 0.081 | 0 | 0.006 | 0.003 |
Operating Income
| -7.964 | -9.613 | -7.418 | -5.569 | -6.211 | -5.275 | -4.106 | -2.37 | -2.377 | -1.583 | -1.583 | -2.035 | -2.827 | -3.495 | -2.087 | -2.097 | -0.262 | -0.168 | -0.084 | 0 | -0.006 | -0.003 |
Operating Income Ratio
| 0 | -2.401 | -4.093 | -4.213 | 0 | -7.452 | 0 | -6.117 | 0 | -9.935 | 0 | -8.907 | 0 | -20.527 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -0.192 | -0.053 | 0.094 | -0.164 | -0.169 | -0.255 | -0.174 | -0.078 | 0.033 | -0.078 | -0.049 | 0.008 | 0.009 | 0.007 | -0.003 | 0.016 | 0.145 | -0.032 | 0.003 | 0 | 0 | 0 |
Income Before Tax
| -8.156 | -9.667 | -7.324 | -5.734 | -6.38 | -5.53 | -4.28 | -2.447 | -2.344 | -1.661 | -1.632 | -2.027 | -2.818 | -3.488 | -2.09 | -2.081 | -0.118 | -0.2 | -0.081 | 0 | -0.006 | -0.003 |
Income Before Tax Ratio
| 0 | -2.415 | -4.041 | -4.337 | 0 | -7.812 | 0 | -6.318 | 0 | -10.425 | 0 | -8.871 | 0 | -20.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 0 | -4.003 | -1.812 | -1.322 | 0 | -0.708 | 0 | -0.387 | 0 | -0.159 | 0 | 0 | 0 | 0 | 0 | 0 | 0.145 | -0.032 | 0.003 | 0 | 0 | 0 |
Net Income
| -8.156 | -5.663 | -5.512 | -4.412 | -6.38 | -4.822 | -4.28 | -2.06 | -2.344 | -1.502 | -1.632 | -2.027 | -2.818 | -3.488 | -2.09 | -2.081 | -0.118 | -0.2 | -0.081 | 0 | -0.006 | -0.003 |
Net Income Ratio
| 0 | -1.415 | -3.041 | -3.337 | 0 | -6.812 | 0 | -5.318 | 0 | -9.425 | 0 | -8.871 | 0 | -20.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.049 | -0.035 | -0.034 | -0.027 | -0.04 | -0.033 | -0.032 | -0.016 | -0.021 | -0.015 | -0.02 | -0.026 | -0.04 | -0.055 | -0.04 | -0.04 | -0.01 | -0.018 | -0.003 | 0 | -0 | 0 |
EPS Diluted
| -0.049 | -0.035 | -0.034 | -0.027 | -0.04 | -0.033 | -0.032 | -0.016 | -0.021 | -0.015 | -0.02 | -0.026 | -0.04 | -0.055 | -0.04 | -0.04 | -0.01 | -0.018 | -0.003 | 0 | -0 | 0 |
EBITDA
| -8.272 | -9.473 | -7.277 | -5.429 | -6.07 | -5.134 | -3.966 | -2.229 | -2.236 | -1.443 | -1.443 | -1.895 | -2.701 | -3.37 | -1.92 | -2.014 | 0.145 | -0.032 | 0.003 | 0 | 0 | 0 |
EBITDA Ratio
| 0 | -2.366 | -4.015 | -4.106 | 0 | -7.254 | 0 | -5.755 | 0 | -9.053 | 0 | -8.292 | 0 | -19.793 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |